NCBiotech News

More than 250 eighth graders representing Cabarrus, Kannapolis City, Richmond County and Rowan-Salisbury school systems celebrated fun and learning at Rockingham Dragway with parents and teacher “coaches” on Saturday in the first BioMoto STEM Challenge.

Humacyte, a Morrisville-based regenerative medicine company bootstrapped with early funding from the North Carolina Biotechnology Center, has received more than $18 million from three sources to help test and commercialize its bioengineered blood vessel, Humacyl.

Triangle Business Journal’s latest annual roundup of the 50 fastest-growing private companies in the Triangle region includes two bioscience companies and seven others that provide valuable life science support functions.

BioFluidica, a Chapel Hill company developing a product using liquid biopsies for cancer detection, has raised $4.1 million in a private equity offering. 

Humacyte, a Morrisville-based regenerative medicine company, has been selected as one of the World Economic Forum’s 30 “Technology Pioneers” for 2017.

The U.S. Special Operations Forces, which include Navy Seals, Army Rangers, and Air Force Special Tactics, have 9,500 people deployed in 90 countries. So they have special needs when it comes to acquisitions from private-sector partners.

One thing was clear, from the opening keynote to the final session, after a unique gathering of North Carolina business and Pentagon procurement leaders: the military is actively seeking private-sector partners to support the health and healing of U.S. warfighters and their families.

Humacyte, a Research Triangle Park-based biotechnology company focused on regenerative medicine, has won one of the first Regenerative Medicine Advanced Therapy (RMAT) designations from the U.S. Food and Drug Administration

Durham-based Baebies Inc. has received clearance from the U.S. Food and Drug Administration to begin marketing a system to screen newborns for four rare but potentially fatal diseases.

FierceBiotech Medical Devices has named Morrisville-based, NCBiotech-backed Humacyte to its annual Fierce 15 list of innovative medical device companies for 2016.

Humacyte, a regenerative medicine company based in Morrisville, has launched a Phase 2 clinical trial of Humacyl, its bioengineered blood vessel, in patients with peripheral arterial disease.

BioMedomics, a medical diagnostics company in Research Triangle Park, won first place among 30 start-up companies competing in an innovation contest at an industry conference in Boston.

Humacyte, a regenerative medicine company based in Morrisville, has received a $9.9 million investment from the California Institute for Regenerative Medicine (CIRM) to support a clinical trial of its potential treatment for kidney disease.

Durham-based Bioventus, a fast-growing global orthobiologics company, has launched its second U.S. product for injection to relieve knee pain for osteoarthritis (OA) sufferers.

The latest company loans awarded by the North Carolina Biotechnology Center in the fourth quarter of FY 2016 bring to 189 the number of North Carolina bioscience companies that have received funding from the Center since its inception in 1984. The companies have received 276 loans totaling just under $34 million.